Sanofi
SNY
729 hedge funds and large institutions have $11.8B invested in Sanofi in 2025 Q2 according to their latest regulatory filings, with 69 funds opening new positions, 281 increasing their positions, 259 reducing their positions, and 100 closing their positions.
9% more call options, than puts
Call options by funds: $87.6M | Put options by funds: $80.3M
8% more repeat investments, than reductions
Existing positions increased: 281 | Existing positions reduced: 259
5% less funds holding
Funds holding: 771 → 729 (-42)
11.1% less ownership
Funds ownership: 21.07% → 9.97% (-11%)
18% less capital invested
Capital invested by funds: $14.4B → $11.8B (-$2.59B)
31% less first-time investments, than exits
New positions opened: 69 | Existing positions closed: 100
67% less funds holding in top 10
Funds holding in top 10: 12 → 4 (-8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Raymond James Financial
St Petersburg,
Florida
|
+$135M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$41.1M |
| 3 |
RP
Regal Partners
Sydney, NSW,
Australia
|
+$40M |
| 4 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
+$35.4M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$282M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$136M |
| 3 |
Dodge & Cox
San Francisco,
California
|
-$75.4M |
| 4 |
Bank of New York Mellon
New York
|
-$74.2M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$55.7M |
SNY Hedge Fund Activity: Q2 2025 in Review
729 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q2 2025, worth a combined $11.8B — down 18% from $14.4B a quarter earlier.
Sellers outnumbered buyers: 100 funds closed out of SNY and 69 opened new positions — a net loss of 31 holders — while 259 trimmed existing stakes and 281 added.
The largest buyer was Raymond James Financial, adding an estimated $135M. The largest seller was T. Rowe Price Associates, cutting an estimated $282M.
- 729 institutional investors held Sanofi (SNY) as of Q2 2025, down from 771 in Q1 2025.
- Funds reported $11.8B of Sanofi stock for Q2 2025, down 18% quarter-over-quarter.
- 69 funds opened new Sanofi positions in Q2 2025 and 100 closed out, a net change of -31 holders.
- The largest Sanofi buyer in Q2 2025 was Raymond James Financial, an estimated $135M added.
- The largest Sanofi seller in Q2 2025 was T. Rowe Price Associates, an estimated $282M sold.
Based on aggregated 13F filings for Q2 2025.